141 related articles for article (PubMed ID: 7908219)
1. Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
Crossen PE; Morrison MJ; Colls BM
Br J Cancer; 1994 Apr; 69(4):759-61. PubMed ID: 7908219
[TBL] [Abstract][Full Text] [Related]
2. Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India.
Fernandez T; Saranath D; Advani SH; Deo MG; Soman CS
Cancer Lett; 1998 Mar; 125(1-2):165-9. PubMed ID: 9566711
[TBL] [Abstract][Full Text] [Related]
3. Elevated frequency of a SstI polymorphism of the Ets-1 oncogene in non-Hodgkin's lymphoma patients.
Crossen PE; Morrison MJ; Colls BM
Cancer Genet Cytogenet; 1995 Jan; 79(1):70-3. PubMed ID: 7850755
[TBL] [Abstract][Full Text] [Related]
4. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
Chenevix-Trench G; Southall M; Kidson C
Int J Cancer; 1989 Jun; 43(6):1034-6. PubMed ID: 2567285
[TBL] [Abstract][Full Text] [Related]
5. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
Isbir T; Yaylim I; Arikan S; Kaytan E; Karşidağ T; Bayrak S; Camlica H
Cancer Detect Prev; 2002; 26(6):454-7. PubMed ID: 12507230
[TBL] [Abstract][Full Text] [Related]
6. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
[TBL] [Abstract][Full Text] [Related]
7. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
[TBL] [Abstract][Full Text] [Related]
8. Allelic variation of the c-raf-1 oncogene in non-Hodgkin's lymphoma.
Chenevix-Trench G; Behm F; Westin E
Leukemia; 1987 Jan; 1(1):82-6. PubMed ID: 2889852
[TBL] [Abstract][Full Text] [Related]
9. EcoRI polymorphism of the L-myc gene in gastric cancer patients.
Dlugosz A; Adler G; Ciechanowicz A; Jaroszewicz-Heigelmann H; Starzynska T
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1231-5. PubMed ID: 12439118
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-myc and c-ras oncogenes in the neoplastic and non-neoplastic cells of Hodgkin's disease.
Benharroch D; Yermiahu T; Geffen DB; Prinsloo I; Gopas J; Segal S; Aboud M
Eur J Haematol; 1995 Sep; 55(3):178-83. PubMed ID: 7672090
[TBL] [Abstract][Full Text] [Related]
11. Familial Hodgkin's and non-Hodgkin's lymphoma: different patterns in first-degree relatives.
Siebert R; Louie D; Lacher M; Schluger A; Offit K
Leuk Lymphoma; 1997 Nov; 27(5-6):503-7. PubMed ID: 9477132
[TBL] [Abstract][Full Text] [Related]
12. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
14. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
15. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
16. Analysis of T-cell receptor and immunoglobulin gene rearrangements in the diagnosis of Hodgkin's and non-Hodgkin's lymphoma.
Gledhill S; Krajewski AS; Dewar AE; Onions DE; Jarrett RF
J Pathol; 1990 Jul; 161(3):245-54. PubMed ID: 2391586
[TBL] [Abstract][Full Text] [Related]
17. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
Lee JT; Innes DJ; Williams ME
J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Sarmanová J; Benesová K; Gut I; Nedelcheva-Kristensen V; Tynková L; Soucek P
Hum Mol Genet; 2001 Jun; 10(12):1265-73. PubMed ID: 11406608
[TBL] [Abstract][Full Text] [Related]
19. Genomic rearrangement of the c-myc proto-oncogene in non-AIDS-related lymphoma in Japan.
Nagai M; Ikeda K; Tasaka T; Irino S
Leukemia; 1991 Jun; 5(6):462-7. PubMed ID: 2056771
[TBL] [Abstract][Full Text] [Related]
20. L-MYC allelotype in renal cell carcinoma.
Presti JC; Hinckley J; Reuter VE
Cancer Genet Cytogenet; 1996 May; 88(1):66-8. PubMed ID: 8630982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
